Home
About
Overview
Sharing Data
ORCID
Help
History (13)
NK cell recruitment limits tissue damage during an enteric helminth infection.
Kidney Transplant Outcomes in Recipients With Cognitive Impairment: A National Registry and Prospective Cohort Study.
Craniospinal involvement in a patient with isolated bone marrow mastocytosis. A case report.
Food label use and its relation to dietary intake among US adults.
Beta 2-microglobulin induces calcium efflux from cultured neonatal mouse calvariae.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Schilsky, Richard
One or more keywords matched the following items that are connected to
Schilsky, Richard
Item Type
Name
Concept
Drug Synergism
Academic Article
Update on biochemical modulation of chemotherapeutic agents.
Academic Article
Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin.
Academic Article
Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer.
Academic Article
Laboratory and clinical studies of biochemical modulation by hydroxyurea.
Academic Article
Inhibiting 5-fluorouracil breakdown: a broken down approach to 5-fluorouracil modulation.
Academic Article
Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer.
Academic Article
Are targeted therapies really targeted?
Academic Article
Synergistic cytotoxicity and DNA strand break formation by bromodeoxyuridine and bleomycin in human tumor cells.
Academic Article
Hydroxyurea and etoposide: in vitro synergy and phase I clinical trial.
Academic Article
Randomized, open-label, phase III study of a 28-day oral regimen of eniluracil plus fluorouracil versus intravenous fluorouracil plus leucovorin as first-line therapy in patients with metastatic/advanced colorectal cancer.
Search Criteria
Drug Synergism